Litcius/Paper detail

Human PARP1 substrates and regulators of its catalytic activity: An updated overview

Tao Zhu, Juyan Zheng, Lingling Huang, Yanhong Wang, Di-Fei Yao, Haibin Dai

2023Frontiers in Pharmacology38 citationsDOIOpen Access PDF

Abstract

Poly (ADP-ribose) polymerase 1 (PARP1) is a key DNA damage sensor that is recruited to damaged sites after DNA strand breaks to initiate DNA repair. This is achieved by catalyzing attachment of ADP-ribose moieties, which are donated from NAD + , on the amino acid residues of itself or other acceptor proteins. PARP inhibitors (PARPi) that inhibit PARP catalytic activity and induce PARP trapping are commonly used for treating BRCA1/2 -deficient breast and ovarian cancers through synergistic lethality. Unfortunately, resistance to PARPi frequently occurs. In this review, we present the novel substrates and regulators of the PARP1-catalyzed poly (ADP-ribosyl)ation (PARylatison) that have been identified in the last 3 years. The overall aim is the presentation of protein interactions of potential therapeutic intervention for overcoming the resistance to PARPi.

Topics & Concepts

ChemistryComputational biologyBiochemistryPharmacologyNanotechnologyBiologyMaterials sciencePARP inhibition in cancer therapyToxin Mechanisms and Immunotoxins
Human PARP1 substrates and regulators of its catalytic activity: An updated overview | Litcius